Learning from airway management in the ED: UK Perspective
This is the transcript for an invited talk at the recent Difficult Airway Society (DAS) 2021 virtual conference. It was lovely to be invited and great of the organisers to create a multidisciplinary opportunity for …
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s
Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for critically ill patients with COVID19. This …
Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s
I am sure you all saw the recent MHRA press release and guidance, discussing the issue of a possible link between the AstraZeneca COVID19 vaccine and a rare type of thrombotic condition of Vaccine induced …
Tocilizumabulous? A special offer on IL-6 with Tocilizumab.
It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it. Maybe not the one intervention …
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s
Hot on the heels of a terrific pun and blog post about the use of Tocilizumab, capturing all the intrigue, hope and caution with the potential use of this novel therapeutic agent for patients with severe …
Tocilizumaybe? Immune modulation in COVID-19 @StEmlyns
I am sure many of you saw the breaking news on the BBC the other week, about a new wonderdrug to strengthen our defences against the tidal wave that is COVID19. This follows a press …
Research, trainees and prioritisation in UK emergency medicine.
The UK Trainee Emergency Research Network (TERN) was created (officially) in 2018 and mentioned previously by Simon & Dan in this early digital outing. The initial mission was to demystify clinical research, improve access to research …
VTE and COVID-19: Would you like to know more?
That’s a leading question. Of course you would. Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated …
The ‘Roid’ to Recovery? REMAP-CAP @ St Emlyn’s
This week JAMA published three important trials on the use of steroids in patients with severe COVID-19, with an additional cherry on top; a subsequent inclusive meta-analysis (totalling 7 RCTs and 1703 patients) from the …
Diagnosis and Treatment of VTE in the COVID-19 era
Ed – this post supports a webinar Dan gave with Thrombosis UK. We hope to link to that content when it’s ready. First of all, thanks to Thrombosis UK for inviting me to speak at …
